Vietnam Office in Philippines Aids Delegation for Dabaco Group Cooperation
vietnams Dabaco Group Eyes Philippine Market with African Swine Fever Vaccine
Table of Contents
- vietnams Dabaco Group Eyes Philippine Market with African Swine Fever Vaccine
- Dabaco Group’s ASF Vaccine: A potential Solution for the Philippines?
- Frequently Asked Questions: Dabaco and the ASF Vaccine
- What is the african Swine Fever (ASF)?
- What is Dabaco Group, and why is it significant in this context?
- what is the Dacovac ASF-2 vaccine?
- why is the Philippines interested in Dabaco’s ASF vaccine?
- What happened during the Philippine delegation’s visit to Vietnam?
- What specific concerns and hopes were expressed by Philippine officials?
- What is the next step in the collaboration between Dabaco and the Philippines?
- what are the potential market opportunities for Dabaco’s vaccine in the Philippines?
- Key Takeaways
- Conclusion
- Frequently Asked Questions: Dabaco and the ASF Vaccine
HANOI, Vietnam (March 31, 2025) – Dabaco Group, a leading Vietnamese company, is seeking to export its African swine fever (ASF) vaccine to the Philippines, highlighting the urgent need for effective disease control measures in the region. The company has requested support from the Vietnam Commercial Office in the Philippines to connect with Filipino partners.
Dabaco’s Vaccine progress and Production
Dabaco Group has pioneered the research and production of a commercial ASF vaccine. The company also invested in the Dabaco Vaccine Factory, which has achieved FMP-OMS certification. The accomplished development of this vaccine is considered a significant achievement for both Dabaco Group and vietnam, with potential benefits extending beyond national borders.Dabaco aims to supply the vaccine to both domestic livestock operations and international markets.
Philippine Delegation Visits Vietnam
Facilitated by the Vietnam Commercial Office, a delegation of 14 representatives from the philippine Department of Agriculture and various companies visited Vietnam to explore potential collaborations with Dabaco Group. The delegation,led by Dr. Constant J. Word, DVM, Undersecretary of Livestock and Corral Birds, included representatives from companies such as Edl Group, East Asia Veterinary Inc., and Universal Robina Corp. The discussions focused not only on vaccines but also on broader agricultural and livestock products.
philippine Officials Express Optimism
During the visit, Dr. Constant J. Word emphasized the devastating impact of ASF on the pig industry, citing its high infectivity and mortality rates. he expressed hope that Vietnam’s success in developing a vaccine could offer a solution to mitigate these losses.
The African swine plague has devastated the pig industry due to its high infegiosity and easy transmission… After Vietnam’s success, we would like [to explore collaboration].
Dr. Eulalio D. Lorenzo, President and Executive Director of the EDL Group, conveyed his support for Dabaco’s efforts.
From the bottom of my heart, I sincerely wish the Dabaco group the successful commercial launch of the Dacovac Asf-2 vaccine… This event marks a significant advance in the prevention and control of the African swine plague…
Dr. Lorenzo also thanked the Vietnam Commercial Office in the Philippines for facilitating the connection between EDL Group and Dabaco Group.
Future Collaboration and Market Prospects
The Vietnam Commercial Office in the Philippines will continue to support negotiations between the parties, with the aim of importing Dabaco’s dacovac ASF-2 vaccine for testing in the philippines. If successful, dabaco’s vaccine, along with another ASF vaccine developed by AVAC company, could possibly dominate the Philippine market.
Dabaco Group’s ASF Vaccine: A potential Solution for the Philippines?
This article explores the potential collaboration between the Vietnamese Dabaco Group and the Philippines to combat African Swine Fever (ASF) through the export and potential use of Dabaco’s ASF vaccine, Dacovac ASF-2.
Frequently Asked Questions: Dabaco and the ASF Vaccine
What is the african Swine Fever (ASF)?
African Swine Fever (ASF) is a highly contagious and deadly viral disease affecting domestic and wild pigs. It’s characterized by high infectivity, meaning it spreads rapidly, and high mortality rates, causing critically important economic losses in the pig farming industry. There is currently no cure or commercially available vaccine in many parts of the world.
What is Dabaco Group, and why is it significant in this context?
Dabaco group is a leading Vietnamese company involved in the research, production, and commercialization of livestock products, including animal feed and vaccines. In this instance, Dabaco Group has pioneered the research and production of a commercial ASF vaccine, Dacovac ASF-2. They have achieved FMP-OMS (Finished Product Manufacturing – Office of Management and Standards) certification for their vaccine factory, a significant achievement that is essential for international trade.
what is the Dacovac ASF-2 vaccine?
The Dacovac ASF-2 vaccine is Dabaco Group’s commercially available vaccine designed to protect pigs from African Swine Fever. At the time of the source article,the vaccine had already been developed and was ready for international commercialization.
why is the Philippines interested in Dabaco’s ASF vaccine?
The Philippines, like many countries, has been severely impacted by ASF, resulting in significant losses in its pig industry. The high infectivity and mortality rates of ASF have devastated pig populations. The success of Dabaco’s vaccine offers a potential solution to mitigate these losses. Philippines is looking at collaboration with Vietnam in an effort to mitigate the spread of the disease and save the pig industry.
What happened during the Philippine delegation’s visit to Vietnam?
Facilitated by the Vietnam Commercial Office, a delegation of 14 representatives from the Philippine Department of Agriculture and various companies visited Vietnam to explore potential collaborations with Dabaco Group. The delegation, led by Dr.Constant J. Word, Undersecretary of Livestock and Corral Birds, included representatives from companies like EDL Group, East Asia Veterinary Inc., and universal Robina Corp. Discussions focused on Dabaco’s vaccine and other agricultural products.
What specific concerns and hopes were expressed by Philippine officials?
Dr. Constant J. Word, DVM, Undersecretary of Agriculture, highlighted the devastating impact of ASF on the pig industry. He expressed hope that Vietnam’s successful growth of a vaccine could provide a solution.
the African swine plague has devastated the pig industry due to its high infegiosity and easy transmission… After Vietnam’s success, we would like [to explore collaboration].
What is the next step in the collaboration between Dabaco and the Philippines?
The Vietnam Commercial Office in the Philippines will facilitate the ongoing negotiations between Dabaco Group and potential Philippine partners. The initial aim is to import the Dacovac ASF-2 vaccine for testing in the Philippines.
what are the potential market opportunities for Dabaco’s vaccine in the Philippines?
If the Dacovac ASF-2 vaccine proves successful in testing, it, along with another ASF vaccine developed by AVAC company, could perhaps dominate the Philippine market. This represents a significant opportunity for Dabaco Group to expand its reach and contribute to the control of ASF in the region.
Key Takeaways
| Key Aspect | Details |
|---|---|
| The Problem | Devastating impact of African Swine Fever (ASF) on the Philippine pig industry. |
| The solution | Dabaco Group’s Dacovac ASF-2 vaccine developed in Vietnam. |
| collaboration | Philippine delegation’s visit to Vietnam to explore partnerships and vaccine import. |
| Future Prospects | Potential dominance of the Philippine market by dabaco and AVAC’s ASF vaccines. |
Conclusion
The collaboration between Dabaco Group and the Philippines represents a significant step towards mitigating the impact of ASF in the region. If successful, the dacovac ASF-2 vaccine could offer a crucial solution for the Philippines’ pig industry, paving the way for a healthier and more sustainable future for pig farming. It will be important to observe the vaccine’s testing phases and see the developments in the coming months.